Literature DB >> 32799206

Inter-α-Trypsin Inhibitor Heavy Chain 5 (ITIH5) Is a Natural Stabilizer of Hyaluronan That Modulates Biological Processes in the Skin.

Sebastian Huth1, Laura Huth2, Yvonne Marquardt2, Katharina Fietkau2, Edgar Dahl3, Philipp R Esser4, Stefan F Martin4, Ruth Heise2, Hans F Merk2, Jens Malte Baron2.   

Abstract

INTRODUCTION: Hyaluronan (HA) is a major component of the skin that exerts a variety of biological functions. Inter-α-trypsin inhibitor heavy chain (ITIH) proteins comprise a family of hyaladherins of which ITIH5 has recently been described in skin, where it plays a functional role in skin morphology and inflammatory skin diseases including allergic contact dermatitis (ACD).
OBJECTIVE: The current study focused on the ITIH5-HA interaction and its potential clinical and functional impact in extracellular matrix (ECM) stabilization.
METHODS: Studying the molecular effects of ITIH5 in skin, we established skin models comprising murine skin cells of Itih5 knockout mice and corresponding wild-type controls. In addition, human dermal fibroblasts with an ITIH5 knockdown as well as a murine recombinant Itih5 protein were established to examine the interaction between ITIH5 and HA using in vitro adhesion and HA degradation assays. To understand more precisely the role of ITIH5 in inflammatory skin diseases such as ACD, we generated ITIH5 knockout cells of the KeratinoSens® cell line.
RESULTS: Using murine skin models, ITIH5 knockdown fibroblasts, and a reactive oxygen species (ROS)-mediated HA degradation assay, we proved that ITIH5 binds to HA, thereby acting as a stabilizer of HA. Moreover, microarray profiling revealed the impact of ITIH5 on biological processes such as skin development and ECM homeostasis. Performing the in vitro KeratinoSens skin sensitization assay, we detected that ITIH5 decreases the sensitizing potential of moderate and strong contact sensitizers.
CONCLUSION: Taken together, our experiments revealed that ITIH5 forms complexes with HA, thereby on the one hand stabilizing HA and facilitating the formation of ECM structures and on the other hand modulating inflammatory responses.
© 2020 S. Karger AG, Basel.

Entities:  

Keywords:  Extracellular matrix stabilization; Hyaluronan; Inflammatory skin disease; Inter-α-trypsin inhibitor heavy chain 5

Mesh:

Substances:

Year:  2020        PMID: 32799206     DOI: 10.1159/000509371

Source DB:  PubMed          Journal:  Skin Pharmacol Physiol        ISSN: 1660-5527            Impact factor:   3.479


  7 in total

1.  The ECM Modulator ITIH5 Affects Cell Adhesion, Motility and Chemotherapeutic Response of Basal/Squamous-Like (BASQ) Bladder Cancer Cells.

Authors:  Michael Rose; Erik Noetzel; Jennifer Kistermann; Julian Eschenbruch; Sandra Rushrush; Lin Gan; Ruth Knüchel; Nadine T Gaisa; Edgar Dahl
Journal:  Cells       Date:  2021-04-28       Impact factor: 6.600

2.  Transcriptome Analysis of Hypoxic Lymphatic Endothelial Cells Indicates Their Potential to Contribute to Extracellular Matrix Rearrangement.

Authors:  Jürgen Becker; Sonja Schwoch; Christina Zelent; Maren Sitte; Gabriela Salinas; Jörg Wilting
Journal:  Cells       Date:  2021-04-24       Impact factor: 6.600

3.  ITIH5, a p53-responsive gene, inhibits the growth and metastasis of melanoma cells by downregulating the transcriptional activity of KLF4.

Authors:  Jia Liu; Feng Cao; Xiaojie Li; Li Zhang; Zhengrong Liu; Xiaodong Li; Jingrong Lin; Chuanchun Han
Journal:  Cell Death Dis       Date:  2021-05-02       Impact factor: 8.469

4.  Deletion of TNFAIP6 Gene in Human Keratinocytes Demonstrates a Role for TSG-6 to Retain Hyaluronan Inside Epidermis.

Authors:  Céline Evrard; Emilie Faway; Evelyne De Vuyst; Olivier Svensek; Valérie De Glas; David Bergerat; Michel Salmon; Olivier De Backer; Bruno Flamion; Hélène Le-Buanec; Catherine Lambert de Rouvroit; Yves Poumay
Journal:  JID Innov       Date:  2021-08-23

5.  ITIH5-Derived Polypeptides Covering the VIT Domain Suppress the Growth of Human Cancer Cells In Vitro.

Authors:  Michael Rose; Sebastian Huth; Marc Wiesehöfer; Josef Ehling; Corinna Henkel; Julia Steitz; Twan Lammers; Jennifer Kistermann; Oliver Klaas; Maximilian Koch; Sandra Rushrush; Ruth Knüchel; Edgar Dahl
Journal:  Cancers (Basel)       Date:  2022-01-19       Impact factor: 6.639

Review 6.  Epidermal Hyaluronan in Barrier Alteration-Related Disease.

Authors:  Céline Evrard; Catherine Lambert de Rouvroit; Yves Poumay
Journal:  Cells       Date:  2021-11-09       Impact factor: 6.600

7.  Urine inter-alpha-trypsin inhibitor family-related proteins may serve as biomarkers for disease activity of lupus.

Authors:  Jun Jiang; Jin Zhao; Yuhua Wang; Dan Liu; Man Zhang
Journal:  J Clin Lab Anal       Date:  2022-07-23       Impact factor: 3.124

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.